Edwards Lifesciences (WBO:EWLS) Long-Term Debt : €549 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Edwards Lifesciences Long-Term Debt?

Edwards Lifesciences's Long-Term Debt for the quarter that ended in Mar. 2024 was €549 Mil.

Edwards Lifesciences's quarterly Long-Term Debt declined from Sep. 2023 (€559 Mil) to Dec. 2023 (€547 Mil) but then increased from Dec. 2023 (€547 Mil) to Mar. 2024 (€549 Mil).

Edwards Lifesciences's annual Long-Term Debt increased from Dec. 2021 (€527 Mil) to Dec. 2022 (€563 Mil) but then declined from Dec. 2022 (€563 Mil) to Dec. 2023 (€547 Mil).

Edwards Lifesciences Long-Term Debt Historical Data

The historical data trend for Edwards Lifesciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Long-Term Debt Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

534.96

489.09

527.20

562.91

547.45

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															557.13	550.75	559.20	547.45	549.42

Edwards Lifesciences (WBO:EWLS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Edwards Lifesciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (WBO:EWLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (WBO:EWLS) Headlines

No Headlines